Latest Conference Articles

As research into novel vaccine approaches for treating advanced prostate cancer continues...

Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer

As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response

With thousands of clinical trials in play, many oncology specialists are reluctant to embrace findings from newly-released studies

Should genomic profiles be used routinely to determine which breast cancer patients receive adjuvant chemotherapy

Personalized treatment in oncology is a popular concept these days, but the goal remains elusive

It is time to rethink the way oncologists in the United States are treating ductal carcinoma in situ

The addition of sorafenib to capecitabine as a first-line therapy for patients with advanced breast cancer

The climate for medical malpractice litigation in breast cancer treatment seems to be worsening

Breast pain is among the most common reasons that women seek medical attention from a breast specialist.